BRAF and cutaneous mastocytosis: Nevertheless, a correct diagnosis of CM metastases is mandatory, because cytological samples may also be used for the predictive evaluation of the BRAF molecular status of the neoplasm, and because immunotherapy has recently been introduced for patients affected by metastatic CM [3].